Twin Focus Capital Partners, LLC Gilead Sciences, Inc. Transaction History

Twin Focus Capital Partners, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $1,744 - $2,505	-28 Reduced 0.65%	4,269 $366,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $1,096 - $1,235	-19 Reduced 0.44%	4,297 $266,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $5,734 - $7,185	99 Added 2.35%	4,316 $257,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $52,617 - $59,722	811 Added 23.81%	4,217 $306,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $541 - $584	8 Added 0.24%	3,406 $238,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $8,378 - $9,154	132 Added 4.04%	3,398 $234,000
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $195,960 - $223,590	3,266 New	3,266 $211,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $370,207 - $421,834	-6,535 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $993 - $1,249	16 Added 0.25%	6,535 $413,000
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $1,302 - $1,512	-18 Reduced 0.28%	6,519 $502,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $8,580 - $10,990	137 Added 2.14%	6,537 $489,000
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $197,184 - $216,896	3,200 Added 100.0%	6,400 $416,000
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $31,255 - $34,500	-500 Reduced 13.51%	3,200 $203,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $228,919 - $256,705	3,700 New	3,700 $250,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Twin Focus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Twin Focus Capital Partners, LLC with notifications on news.